4.5 Review

Chronic kidney disease and the gut microbiome

期刊

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
卷 316, 期 6, 页码 F1211-F1217

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajprenal.00298.2018

关键词

chronic kidney disease; disease progression; gastrointestinal tract; indoxyl sulfate; metaproteomics; microbiome

资金

  1. Department of Veterans Affairs
  2. National Institute of Diabetes and Digestive and Kidney Diseases [1R01 DK-101034]
  3. National Institute of General Medical Sciences Institutional Development Award Centers of Biomedical Research Excellence Grant [1-P20-GM-121293]

向作者/读者索取更多资源

The gut microbiome is composed of a diverse population of bacteria that have beneficial and adverse effects on human health. The microbiome has recently gained attention and is increasingly noted to play a significant role in health and a number of disease states. Increasing urea concentration during chronic kidney disease (CKD) leads to alterations in the intestinal flora that can increase production of gut-derived toxins and alter the intestinal epithelial harrier. These changes can lead to an acceleration of the process of kidney injury. A number of strategies have been proposed to interrupt this pathway of injury in CKD. The purpose of this review is to summarize the role of the gut microbiome in CKD, tools used to study this microbial population, and attempts to alter its composition for therapeutic purposes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据